5-ketomilbemycins producing strain and application thereof
By developing Streptomyces in the bulb, which is tolerant to Streptomyces HS-5-OXO-MIL-116 and optimizing the culture medium formula, the problem of the impact of the bulb-adversarial genetically engineered bacteria YZ1-10 was solved, and the 5-keto group was significantly improved The production efficiency of mirbemycin reaches 6964mg/L, meeting the needs of industrial production.
Patent Information
- Application Number
- CN202410815244.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-24
- Publication Date
- 2024-11-22
AI Technical Summary
During the fermentation process, the impact of the vegetation hostile genetically engineered bacteria YZ1-10 leads to a slowdown in the growth rate of high yields and a decrease in total output, which cannot meet the needs of industrial production.
A new Streptomyces Icelandicum HS-5-OXO-MIL-116 was developed. Through NTG-bound Fiber tolerant complex mutagenesis method, a strain that can tolerate Fiber was obtained, using specific solids and nutrient media. The formula performs aerobic growth, which improves the production efficiency of 5-ketomyrbemycin.
The production titer of 5-ketomyrbemycin reached 6964 mg/L, which was better than the 3562 mg/L of the original genetically engineered strain YZ1-10, meeting the needs of industrial production.
Smart Images

Figure BDA0004907390200000011 
Figure BDA0004907390200000061 
Figure BDA0004907390200000081
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of microbial engineering, and in particular to a 5-ketomilbemycin high-yielding Streptomyces bingchengensis and application thereof in preparing 5-ketomilbemycin. Background Art
[0002] Milbemycin is a macrolide anthelmintic drug, also known as mibemycin in the world. It was discovered by Sankyo Co., Ltd. in Japan in 1967. After years of improvement, it was officially launched in 1986 under the trade name of milbemycinoxime. Milbemycin also has a good control effect on various mites, agricultural pests and gardening pests, killing target mites and forming a long-term control. In addition, the acaricidal activity of milbemycin is not easily affected by temperature and its mechanism of action is different from that of traditional acaricides. It still has a high preventive effect on some resistant mites, so it is considered to be the best acaricide in the world today. Milbemycin oxime is an oxime derivative of milbemycin A3 and milbemycin A4. Milbemycin oxime has a good effect on controlling and preventing most common parasitic diseases, has a broad-spectrum control activity, high activity, small dosage, is safe for humans and animals, does not pollute the environment, is harmless to natural enemies, and is not easy to produce resistance. It is usually used to prevent heartworm disease, control dog and cat diseases caused by nematodes and hookworms, and canine whipworm disease. It is less toxic to dogs sensitive to avermectins, so it has good market prospects.
[0003] Milbemycin oxime is mainly produced by a semi-synthetic method. First, milbemycin-producing Streptomyces is fermented to obtain milbemycin A3 and A4; then the C-5 hydroxyl group of milbemycin A3 and A4 is oxidized to ketone to obtain 5-ketomilbemycin A3 and A4 (structural formulas are shown in Formula 1 and Formula 2), respectively; and then hydroxylamine hydrochloride is reacted in dioxane-methanol-water to obtain milbemycin oxime.
[0004]
[0005] In the known milbemycin biosynthesis pathway, 5-keto milbemycin is produced first. Under the catalysis of C5-keto reductase encoded by milF gene, C-5 keto group is reduced to hydroxyl group to obtain the final fermentation products milbemycin A3 and A4. Our company knocked out milF gene through genetic engineering technology, blocked the C-5 keto reduction reaction in the organism, and successfully obtained genetically engineered bacteria YZ1-10 that can directly ferment and produce 5-keto milbemycin, eliminating the oxidation reaction step, simplifying the synthesis process of milbemycin oxime, and applied for the relevant patent ZL201310541829.8.
[0006] When our company further verified the potency of the genetically engineered bacteria YZ1-10 in the tank, it was found that a large number of bubbles were generated during the fermentation process, and the foam top tank increased the risk of contamination, and it was necessary to add bubble enemy to inhibit it. However, it was found that bubble enemy had a great impact on the production of toxins by bacteria. After adding bubble enemy, the growth rate of high toxin production slowed down, and the total output was significantly reduced, which could not meet the needs of industrial production. Therefore, an effective method is urgently needed to solve the impact of bubble enemy genetically engineered bacteria YZ1-10 production of toxins during fermentation. Summary of the invention
[0007] One of the purposes of the present invention is to provide a new Streptomyces bingchengensis sp. HS-5-OXO-MIL-116 capable of producing 5-ketomilbemycin, and its deposit number is CGMCC NO.29877.
[0008] The microbial strain of Streptomyces bingchengensis HS-5-OXO-MIL-116 described in the present invention was deposited in the General Microbiology Center of the China Microorganism Culture Collection Administration (address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences) on February 22, 2024, with a deposit number of CGMCC NO.29877, a classification name of Streptomyces bingchengensis sp., and was registered to prove its survival.
[0009] The present invention also aims to provide an application of Streptomyces HS-5-OXO-MIL-116 in producing 5-ketomilbemycin or a pharmaceutical composition containing 5-ketomilbemycin.
[0010] The present invention also provides a method for culturing the growth of 5-ketomilbemycin spores, which uses the above-mentioned Streptomyces HS-5-OXO-MIL-116 to tolerate aerobic growth in a solid culture medium containing assimilable carbon sources and / or nitrogen sources, bubblegum and agar.
[0011] In a preferred embodiment, the assimilable carbon source in the solid culture medium is selected from one of glucose, sucrose, mannitol, D-galactose, dextrin, soluble starch, maltose, or a combination thereof, preferably mannitol.
[0012] In a preferred embodiment, the assimilable nitrogen source in the solid culture medium is selected from yeast extract powder, malt extract powder, soybean cake powder, enzymatic hydrolyzed casein, acidified hydrolyzed casein, skimmed milk powder or a combination thereof, preferably soybean cake powder.
[0013] In a preferred embodiment, the solid culture medium contains 10-50 g / L mannitol, 10-50 g / L soybean cake powder, 10-30 g / L agar, and 1-10 g / L folate, and the pH before disinfection is 7.0-7.2. Preferably, the solid culture medium contains 20 g / L mannitol, 20 g / L soybean cake powder, 20 g / L agar, and 5 g / L folate, and the pH before disinfection is 7.2.
[0014] In a preferred embodiment, the temperature of the aerobic growth is 26-30°C, preferably 28°C; the time of the aerobic growth is 7-10 days, preferably 8 days.
[0015] The present invention further provides a method for preparing 5-ketomilbemycin, which utilizes the above-mentioned Streptomyces HS-5-OXO-MIL-116 to carry out aerobic fermentation in a nutrient medium containing assimilable carbon source and / or nitrogen source and iodine.
[0016] In a preferred embodiment, the assimilable carbon source in the nutrient medium is selected from one of soluble starch, maltodextrin, sucrose, glucose, glycerol, fructose, sorbitol, mannitol, maltose, lactose, galactose, xylan, industrial molasses, or a combination of the above substances, preferably sucrose.
[0017] In a preferred embodiment, the assimilable nitrogen source in the nutrient medium is selected from soybean cake powder, yeast extract, malt extract, skimmed milk powder, yeast extract powder, yeast peptone, peanut cake powder, yeast powder, corn steep powder, gluten powder, wheat germ flakes, soy peptone, corn flour, soybean meal, or a combination of the above substances, preferably a combination of soybean cake powder, peanut cake powder, gluten powder, or corn flour with yeast extract or malt extract, and further preferably a combination of soybean cake powder, yeast extract and malt extract.
[0018] In a preferred embodiment, the nutrient medium further includes an inorganic salt, which is selected from one of zinc sulfate, magnesium sulfate, ferrous sulfate, copper sulfate, manganese sulfate, dipotassium hydrogen phosphate, potassium chloride, sodium chloride, magnesium chloride, cobalt chloride, sodium molybdate, trisodium citrate, calcium carbonate, calcium chloride, or a combination of the above substances, preferably a combination of ferrous sulfate, dipotassium hydrogen phosphate, calcium carbonate, and magnesium sulfate.
[0019] In a preferred embodiment, the nutrient medium contains sucrose, soybean cake powder, malt extract, yeast extract, dipotassium hydrogen phosphate, magnesium sulfate, ferrous sulfate, calcium carbonate, and folate; preferably, the nutrient medium contains 100-500 g / L sucrose, 10-50 g / L soybean cake powder, 1-10 g / L malt extract, 1-10 g / L yeast extract, 0.01-0.1 g / L ferrous sulfate, 0.1-1 g / L dipotassium hydrogen phosphate, 0.1-1 g / L magnesium sulfate, 1-10 g / L calcium carbonate, and 1-10 g / L folate; further preferably, the nutrient medium contains 160 g / L sucrose, 20 g / L soybean cake powder, 5 g / L malt extract, 5 g / L yeast extract, 0.05 g / L ferrous sulfate, 0.5 g / L dipotassium hydrogen phosphate, 0.5 g / L magnesium sulfate, 3.0 g / L calcium carbonate, and 2 g / L folate.
[0020] In a preferred embodiment, the temperature of the aerobic fermentation is 26-30°C, preferably 28°C; the pH of the nutrient medium is 6.0-8.0, preferably 6.8-7.2; and the time of aerobic fermentation is 240-400 hours, preferably 264-312 hours.
[0021] The 5-ketomilbemycin described in the present invention refers to the sum of 5-ketomilbemycin A3 and A4. In other words, the potency of 5-ketomilbemycin measured in the present invention is the sum of the potencies of 5-ketomilbemycin A3 and A4.
[0022] The 5-ketomilbemycin of the present invention is detected by HPLC under the following conditions:
[0023] Chromatographic column: Elite ODS2 (4.6×150mm, 5μm)
[0024] Column temperature: 25°C;
[0025] Injection volume: 5 μL;
[0026] Flow rate: 1 mL / min;
[0027] Detection wavelength: 240nm;
[0028] Analysis time: 15min;
[0029] Mobile phase: acetonitrile: water = 85:15 (v / v);
[0030] Among them, the retention time of the 5-ketomilbe A3 peak is about 6.0 min; the retention time of the 5-ketomilbe A4 peak is about 7.4 min.
[0031] The main biological characteristics of the oxalis tolerant mutagenic strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the invention are: the colony morphology is round, the surface is convex, the colony diameter is about 8-12 mm, the colony surface has wrinkles and grooves, the middle is convex, the matrix hyphae is well-developed, the combination with the culture medium is not tight, and it is easy to be picked up, the matrix hyphae is ochre brown, the aerial hyphae is agate gray, the spore production is rich, the early signal is white, and the late signal turns to beige, and there is no soluble pigment.
[0032] Compared with the prior art, the present invention has the following beneficial effects:
[0033] The HS-5-OXO-MIL-116 (CGMCC NO. 29877) of the present invention is a brand-new 5-ketomilbemycin-producing bacterium, and its ability to produce 5-ketomilbemycin is greatly improved compared with other strains in the prior art, and the titer can be as high as 6964 mg / L, while the titer of 5-ketomilbemycin produced by the genetically engineered bacterium YZ1-10 disclosed in ZL201310541829.8 is only 3562 mg / L, which is more conducive to realizing industrial production. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 The culturing characteristics of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) in Example 2 are shown.
[0035] Figure 2 The culturing characteristics of strain HS-5-OXO-MIL-116 (CGMCC NO. 29877) and strain YZ1-10 in Example 4 on eight culture media, including ISP1, ISP2, ISP3, ISP4, ISP5, Gao's No. 1, calcium malate and nutrient agar, were compared. DETAILED DESCRIPTION
[0036] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.
[0037] The materials and reagents used in the following examples, unless otherwise specified, can be obtained from commercial sources. The total DNA template of the Streptomyces was extracted with reference to the relevant contents in the Molecular Cloning Experiment Guide and the Pitcher method (Pitcher et al., 1989) improved by the lysozyme method, and the 16S rRNA gene was amplified using universal primers 27F (SEQ ID NO: 1) and 1495R (SEQ ID NO: 2). After the PCR product was detected and purified, it was directly sequenced, and the sequencing was performed by Shanghai Sangon Biotechnology Co., Ltd.
[0038] The present invention will be further described below in conjunction with specific examples. It should be understood that the following examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention.
[0039] Example 1: Strain Source
[0040] Streptomyces HS-5-OXO-MIL-116 is a white spore-producing strain obtained by using the strain YZ1-10 (disclosed in ZL201310541829.8) with the milF gene knocked out as the starting source through the NTG combined with the bubble-resistant tolerance composite mutagenesis method.
[0041] Strain YZ1-10 was used as the starting bacterial source. After being cultured in a solid slant medium at 28°C for 8 days, the mycelium was scraped off with an inoculation spatula under sterile conditions to obtain a bacterial suspension for NTG (nitrosoguanidine) mutagenesis treatment.
[0042] Weigh 2 mg of NTG crystals and dissolve them in 2 mL of sterile Tris buffer (pH 6.0). Use a pipette to draw 1 mL of NTG solution and add it to 1 mL of bacterial suspension. Shake it on a rotary or reciprocating shaker at 28°C for 1 hour. The remaining specific steps are as follows:
[0043] (1) Preparation and cultivation of mycelium
[0044] The solid culture medium (also referred to as the slant culture medium of the present invention) is formulated as follows: 20 g / L mannitol, 20 g / L soybean cake powder, 20 g / L agar, 5 g / L bubbling agent, pH 7.2 before sterilization. After sterilization at 121°C for 20 minutes, the culture medium is cooled to 50-60°C and poured into a plate. The mutagenic bacterial suspension is appropriately diluted, and 0.2 mL of the bacterial liquid is applied to the plate of the solid formula. The unmutated bacterial suspension is also appropriately diluted and applied to the plate of the solid formula as a control. After culturing in a constant temperature incubator at 28°C in the dark for 8 days, the single colony is expanded and turned over to the slant. The expanded slant is further cultured in the dark for 8 days according to the above method until the mycelium matures.
[0045] (2) Seed solution preparation and cultivation
[0046] Seed culture medium formula (g / L): sucrose 10g / L, skimmed milk powder 1g / L, peptone 3.5g / L, yeast extract 5g / L, potassium dihydrogen phosphate 5×10 -1 g / L, pH 7.2 before sterilization; triangular shake flask liquid volume 30mL / 250mL, 121℃ sterilization for 20min. Each seed shake flask is inoculated with about 1cm 2 The bacterial lawn was cultured at 28°C and 250 rpm with shaking for 30 hours.
[0047] (3) Preparation and cultivation of fermentation medium (also referred to as nutrient medium of the present invention)
[0048] Formula of fermentation medium (g / L): sucrose 160g / L, soybean cake powder 20g / L, yeast extract 5g / L, malt extract 5g / L, dipotassium hydrogen phosphate 0.5g / L, magnesium sulfate 0.5g / L, ferrous sulfate 0.05g / L, calcium carbonate 3g / L, 2g / L of chloranil, pH 7.2 before disinfection; triangular shaking bottle liquid volume 25mL / 250mL, 121℃ sterilization for 20min. Seed liquid is inoculated into fermentation medium at an inoculation rate of 6% (volume ratio), culture temperature is 28℃, rotation speed is 250rpm, and culture is carried out for 264 hours.
[0049] 300 single colonies were selected after NTG mutagenesis treatment, and 300 test tube slopes were propagated in turn for shake flask fermentation. The content of 5-ketomilbemycin in the fermentation broth was detected by HPLC. The high-yield strain selected was the mutagenic strain HS-5-OXO-MIL-116 (CGMCC NO.29877).
[0050] Example 2: Morphological, cultural, physiological and biochemical characteristics of Streptomyces HS-5-OXO-MIL-116 (CGMCC NO.29877).
[0051] The experiment was conducted with reference to the relevant contents in books such as "Manual of Identification of Streptomyces", "Classification and Identification of Actinomycetes", and "Manual of Identification of Common Bacterial Systems": the color judgment was compared with the colors in the RAL K7 color card.
[0052] 1. Strain number: HS-5-OXO-MIL-116 (CGMCC NO.29877).
[0053] 2. Culturological characteristics of strains: After culturing HS-5-OXO-MIL-116 (CGMCC NO.29877) on solid culture medium (mannitol 20g / L, soybean cake powder 20g / L, agar 20g / L, 5g / L, pH 7.2 before disinfection) at 28°C for 8 days, the colony morphology is round, the surface is convex, the colony diameter is about 8-12mm, the colony surface is wrinkled, there are grooves, the middle is convex, the matrix hyphae is well-developed, the combination with the culture medium is not tight, and it is easy to pick up. The matrix hyphae is ochre brown, the aerial hyphae is agate gray, the spores are abundant, the early signal is white, and the later signal turns to beige, and there is no soluble pigment. The results are shown in Figure 1 .
[0054] For other cultural characteristics, ISP1, ISP2, ISP3, ISP4, ISP5, nutrient agar, calcium malate, and Gao's No. 1 culture media were used. After culturing at 28°C for 8 days, the colonies, mycelium, spores, and pigment production were observed. The results are shown in Table 1.
[0055] Table 1 Culture characteristics of strain HS-5-OXO-MIL-116 (CGMCC NO.29877) on 8 culture media
[0056]
[0057] 3. Physiological and biochemical characteristics test: Results are shown in Tables 2 to 7.
[0058] a) Utilization of carbon sources: ISP9 was used as the basic culture medium, and the final concentration of various carbon sources was 1.0%, see Table 2.
[0059] b) Utilization of inorganic nitrogen source: ISP9 was used as the basic culture medium, and the concentrations of potassium nitrate and ammonium sulfate were both 0.1%, see Table 2.
[0060] c) Degradation test and NaCl tolerance test The basic culture medium used was GYEA (pH 6.8). The concentrations of various degradation products and the degradation test results are shown in Table 3; the NaCl tolerance test results are shown in Table 7.
[0061] d) The catalase test, pH test and temperature test all used ISP2 medium. The catalase test results are shown in Table 4, the pH test results are shown in Table 5, and the temperature test results are shown in Table 6.
[0062] e) MR, VP and other experiments adopted the methods of the Manual of Identification of Common Bacterial Systems, and the results are shown in Table 4.
[0063] f) Except for the temperature experiment, all experiments were cultured at 28°C for 8 days.
[0064] Table 2 Utilization of carbon and nitrogen sources by strain HS-5-OXO-MIL-116 (CGMCC NO.29877)
[0065] Carbon source Growth Carbon source Growth Inorganic nitrogen sources Growth D-Glucose 4 Salicin 3 Ammonium sulfate + D-Raffinose 3 D-Lactose 3 Potassium Nitrate + D-Xylose 2 Galactose 3 D-Sorbitol 3 Inositol 2 L-arabinose 1 Mannitol 2 glycerin 3 Glycine 1 maltose 3 Xylan 1 D-Fructose 2 Inulin 3 D-sucrose 4 Rhamnose 4
[0066] Table 3 Degradation test results of strain HS-5-OXO-MIL-116 (CGMCC NO.29877)
[0067] Degradation products Degradation product concentration result* Degradation products Degradation product concentration result Adenine 0.5% 1,+ Oxidase 1.0% - Guanine 0.5% 3,- Tween-40 1.0% 3,+ Xanthine 0.4% 3,- Tween-60 1.0% 3,+ Xylan 0.4% 1,- Tween-80 1.0% 3,+ Hypoxanthine 0.4% 3,-
[0068] Table 4 Main physiological and biochemical characteristics of strain HS-5-OXO-MIL-116 (CGMCC NO.29877)
[0069] Test Project result Test Project result Test Project result Gelatin liquefaction + Milk peptone + Cellulose Utilization - Starch hydrolysis + Nitrate reduction + Catalase - Milk curdling - Hydrogen sulfide production - Melanin production + VP Experiment - MR experiment -
[0070] Table 5 pH test for growth of strain HS-5-OXO-MIL-116 (CGMCC NO.29877)
[0071] pH 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 Growth 0 0 0 0 0 4 4 4 4
[0072] Table 6 Temperature test for growth of strain HS-5-OXO-MIL-116 (CGMCC NO.29877)
[0073] Temperature(℃) 7 14 28 37 45 Growth 0 0 4 0 0
[0074] Table 7 Tolerance of strain HS-5-OXO-MIL-116 (CGMCC NO.29877) to NaCl
[0075] NaCl concentration (%) 1.0 4.0 7.0 10.0 Strain growth 2 0 0 0
[0076] *Note: In Table 2-7: 0, no growth; 1, very weak growth; 2, able to grow, with a small number of spores; 3, good growth, with a large number of spores; 4, the best growth, with abundant spores; +, positive; -, negative.
[0077] Example 3: Bacterial species identification
[0078] 1. 16S rDNA sequence analysis of Streptomyces HS-5-OXO-MIL-116 (CGMCC NO.29877)
[0079] The experiment was conducted with reference to the relevant contents in the book "Molecular Cloning Experiment Guide". Mycelium was collected, and then total DNA was extracted using an actinomycete DNA extraction kit (purchased from Beijing Sanbo Yuanzhi Biotechnology Co., Ltd.). Universal primers 27F (SEQID NO: 1) / 1495R (SEQ ID NO: 2) were used for 16S rDNA sequence amplification. The amplification system and PCR reaction procedure are shown in Table 8. 0.8% agarose gel electrophoresis was used for PCR product detection. The PCR product was purified and recovered using the SanPrep column PCR purification product kit purchased from Shanghai Sangon Biotechnology Co., Ltd. The purified PCR product was directly sent to Shanghai Sangon Biotechnology Co., Ltd. for sequence determination.
[0080] Table 8 PCR amplification system and reaction procedure
[0081]
[0082] The 16S rDNA sequence of strain HS-5-OXO-MIL-116 (CGMCC NO.29877) was proofread and compared with the sequences of related species and genera in the GenBank database by BLAST to determine the taxonomic status of the strain.
[0083] The 16S rDNA sequence (SEQ ID NO: 3) obtained from strain HS-5-OXO-MIL-116 (CGMCC NO. 29877) was submitted to NCBI for BLAST comparison with related sequences in GenBank. The results are shown in Table 9 (only model strains with higher homology are listed in the table).
[0084] Table 9 Homology of strain HS-5-OXO-MIL-116 (CGMCC NO.29877) and typical model strains
[0085]
[0086]
[0087] By sequencing the 16S rDNA region of strain HS-5-OXO-MIL-116 (CGMCC NO.29877) and performing homologous sequence BLAST comparison with sequences of related species and genera in the GenBank database, combined with the experimental results of morphological and cultural characteristics of strain HS-5-OXO-MIL-116 (CGMCC NO.29877), it was found that the classification characteristics of this strain and Streptomyces bingchengensis strain 226541 were very similar, and the homology was as high as 99.93%. Therefore, strain HS-5-OXO-MIL-116 (CGMCC NO.29877) was identified as a Streptomyces bingchengensis strain.
[0088] Example 4: The physiological and biochemical comparison between the Streptomyces HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention and the strain YZ1-10 is as follows:
[0089] The morphological characteristics, culturing characteristics and physiological and biochemical characteristics of the present invention's Streptomyces HS-5-OXO-MIL-116 (CGMCC NO. 29877) and strain YZ1-10 are greatly different. The culturing characteristics of the present invention's strain HS-5-OXO-MIL-116 (CGMCC NO. 29877) and strain YZ1-10 are compared in Tables 10 and Figure 2 , the comparison of physiological and biochemical characteristics is shown in Table 11.
[0090] Table 10 Comparison of culture characteristics of strain HS-5-OXO-MIL-116 (CGMCC NO.29877) and strain YZ1-10 on 8 culture media
[0091]
[0092]
[0093] Table 11 Comparison of physiological and biochemical characteristics between strain HS-5-OXO-MIL-116 (CGMCC NO.29877) and strain YZ1-10
[0094]
[0095] Note: In Table 11, 0, no growth; 1, very weak growth; 2, able to grow, with a small number of spores; 3, good growth, with a large number of spores; 4, the best growth, with abundant spores; +, positive; -, negative, w, doubtful / weakly positive.
[0096] The comparison of the culture characteristics and physiological and biochemical characteristics of the strain HS-5-OXO-MIL-116 (CGMCC NO. 29877) of the present invention and the strain YZ1-10 on ISP4 medium is shown in Table 12. It can be seen from Table 12 that the culture characteristics of the strain HS-5-OXO-MIL-116 (CGMCC NO. 29877) of the present invention and the strain YZ1-10 on ISP4 medium are different, and there are differences in physiological and biochemical characteristics such as adenine degradation, hypoxanthine degradation, and milk peptone.
[0097] Table 12 Comparison of culture characteristics and physiological and biochemical characteristics between strain HS-5-OXO-MIL-116 (CGMCC NO.29877) and strain YZ1-10
[0098]
[0099] Note: In Table 12, 0, no growth; 1, very weak growth; 2, able to grow, with a small number of spores; 3, good growth, with a large number of spores; 4, the best growth, with abundant spores; +, positive; -, negative.
[0100] Combined with the morphology, culture characteristics and DNA sequence identification results of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention, it can be seen that the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention belongs to the Streptomyces bingchengensis strain, and it is different from the starting strain YZ1-10. Therefore, the Streptomyces bingchengensis HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention is a new 5-ketomilbemycin-producing bacterial strain obtained by the NTG combined with the bubble-resistant tolerance composite mutagenesis method.
[0101] Example 5: Aerobic growth experiment of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention in a solid culture medium containing soybean meal as a nitrogen source
[0102] (1) Preparation and culture of slant colonies
[0103] The carbon source of the slant culture medium is 20 g / L mannitol; the nitrogen source is 10 g / L, or 20 g / L, or 50 g / L soybean cake powder, 20 g / L agar, 5 g / L foetida, and the pH before disinfection is 7.2.
[0104] Sterilize with high-pressure steam at 121°C for 20 min. When the culture medium cools to 50-60°C, place it on a slope. Use a sterile inoculation loop to inoculate a ring of spores on a clean bench. Spread it evenly and culture it at 28°C in the dark for 8 days.
[0105] (2) Preparation and cultivation of seed culture medium
[0106] Seed culture medium formula (g / L): sucrose 10g / L, skimmed milk powder 1g / L, peptone 3.5g / L, yeast extract 5g / L, potassium dihydrogen phosphate 5×10 -1 g / L, pH 7.2 before disinfection.
[0107] The volume of the triangular shake flask is 30mL / 250mL, and it is sterilized at 121℃ for 20min. Each seed shake flask is inoculated with about 1cm 2 The bacterial lawn was cultured at 28°C and 250 rpm with shaking for 30 hours.
[0108] (3) Preparation and cultivation of fermentation medium
[0109] Fermentation medium formula (g / L): sucrose 160g / L, soybean cake powder 20g / L, yeast extract 5g / L, malt extract 5g / L, dipotassium hydrogen phosphate 0.5g / L, magnesium sulfate 0.5g / L, ferrous sulfate 0.05g / L, calcium carbonate 3.0g / L, dapoxetine 2g / L, pH 7.2 before disinfection.
[0110] The volume of the triangular shake flask was 25 mL / 250 mL, and sterilized at 121° C. for 20 min. The seed liquid was inoculated into the fermentation medium at a volume ratio of 6%, and the culture temperature was 28° C., the rotation speed was 250 rpm, and the culture was carried out for 264 hours.
[0111] The results of the aerobic growth experiment of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention are shown in Table 13 after HPLC detection. As can be seen from Table 13, the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention is cultured in the three solid culture media in the following table, and the titer of the obtained 5-ketomilbemycin is relatively high, among which the formula ② has the highest titer.
[0112] Table 13. Aerobic growth experiment of strain HS-5-OXO-MIL-116 (CGMCC NO.29877) on solid medium
[0113]
[0114]
[0115] Example 6 Aerobic fermentation experiment of the nutrient medium of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention containing soybean meal, peanut meal, corn meal and gluten meal as nitrogen source.
[0116] (1) Preparation and culture of slant colonies
[0117] The slant culture medium used mannitol 20g / L, soybean cake powder 20g / L, agar 20g / L, and 5g / L of sapote, and the pH before sterilization was 7.2. The slant high pressure steam sterilization and culture were the same as in Example 5
[0118] (2) Preparation and culture of seed culture medium are the same as in Example 5
[0119] (3) Preparation and cultivation of fermentation medium
[0120] Fermentation medium formula (g / L): sucrose 160g / L as carbon source; soybean cake powder 20g / L, peanut cake powder 20g / L, gluten powder 20g / L, corn powder 20g / L as nitrogen source, yeast extract 5g / L, malt extract 5g / L; potassium dihydrogen phosphate 0.5g / L, magnesium sulfate 0.5g / L, ferrous sulfate 0.05g / L, calcium carbonate 3.0g / L, dapoxetine 2g / L, pH 7.2 before digestion.
[0121] The volume of the triangular shake flask was 25 mL / 250 mL, and sterilized at 121° C. for 20 min. The seed liquid was inoculated into the fermentation medium at a volume ratio of 6%, and the culture temperature was 28° C., the rotation speed was 250 rpm, and the culture was carried out for 264 hours.
[0122] The aerobic fermentation experimental results of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention are shown in Table 14 after HPLC detection. As can be seen from Table 14, the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention is fermented in the four nutrient culture media in the following table, and the titer of the obtained 5-ketomilbemycin is relatively high, among which the formula ① has the highest titer.
[0123] Table 14 Aerobic fermentation experiment of nutrient medium of strain HS-5-OXO-MIL-116 (CGMCC NO.29877)
[0124]
[0125]
[0126] Example 7: Preparation of 5-ketomilbemycin by shake flask fermentation of the strain HS-5-OXO-MIL-116 (CGMCC No. 29877) of the present invention and the starting strain YZ1-10
[0127] (1) Preparation and culture of slant colonies
[0128] The slant culture medium used mannitol 20g / L, soybean cake powder 20g / L, agar 20g / L, and bubble-digestive 5g / L, with a pH of 7.2 before disinfection.
[0129] Sterilize with high-pressure steam at 121°C for 20 min. When the culture medium cools to 50-60°C, place it on a slope. Use a sterile inoculation loop to inoculate a ring of spores on a clean bench. Spread it evenly and culture it at 28°C in the dark for 8 days.
[0130] (2) Preparation and cultivation of seed culture medium
[0131] Seed culture medium formula (g / L): sucrose 10g / L, skimmed milk powder 1g / L, peptone 3.5g / L, yeast extract 5g / L, potassium dihydrogen phosphate 5×10 -1 g / L, pH 7.2 before disinfection.
[0132] The volume of the triangular shake flask is 30mL / 250mL, and it is sterilized at 121℃ for 20min. Each seed shake flask is inoculated with about 1cm 2 The bacterial lawn was cultured at 28°C and 250 rpm with shaking for 30 hours.
[0133] (3) Preparation and cultivation of fermentation medium
[0134] Fermentation medium formula (g / L): sucrose 160g / L, soybean cake powder 20g / L, yeast extract 5g / L, malt extract 5g / L, dipotassium hydrogen phosphate 0.5g / L, magnesium sulfate 0.5g / L, ferrous sulfate 0.05g / L, calcium carbonate 3.0g / L, dapoxetine 2g / L, pH 7.2 before disinfection.
[0135] The triangular shake flask is filled with 25mL / 250mL of liquid and sterilized at 121°C for 20min. The seed liquid is inoculated with a 6% (volume ratio) inoculation amount into the fermentation medium, the culture temperature is 28°C, the rotation speed is 250rpm, and the culture is carried out for 264 hours. HPLC detection shows that the fermentation unit of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention is 6964mg / L, and the fermentation unit of YZ1-10 is 3562mg / L. It can be seen from the above that the phlegm tolerance titer of the strain HS-5-OXO-MIL-116 (CGMCC NO.29877) of the present invention is significantly better than that of the strain YZ1-10.
[0136] Sequence Listing
[0137]
[0138]
Claims
1. A Streptomyces bingchengensis sp. HS-5-OXO-MIL-116, whose deposit number is (CGMCC NO.29877).
2. Use of the Streptomyces HS-5-OXO-MIL-116 according to claim 1 in the production of 5-ketomilbemycin or a pharmaceutical composition containing 5-ketomilbemycin.
3. A method for growing 5-ketomilbemycin spores, characterized in that: The Streptomyces HS-5-OXO-MIL-116 described in claim 1 is used to tolerate aerobic growth in a solid culture medium containing assimilable carbon source and / or nitrogen source, bubo and agar.
4. The method according to claim 3, characterized in that The assimilable carbon source in the solid culture medium is selected from one of glucose, sucrose, mannitol, D-galactose, dextrin, soluble starch, maltose or a combination thereof, preferably mannitol.
5. The method according to claim 3, characterized in that: The assimilable nitrogen source in the solid culture medium is selected from yeast extract powder, malt extract powder, soybean cake powder, enzymatic hydrolyzed casein, acidified hydrolyzed casein, skimmed milk powder or a combination thereof, preferably soybean cake powder.
6. The method according to any one of claims 3 to 5, characterized in that: The solid culture medium contains 10-50 g / L mannitol, 10-50 g / L soybean cake powder, 10-30 g / L agar, and 1-10 g / L folate, and the pH value before disinfection is 7.0-7.
2. Preferably, the solid culture medium contains 20 g / L mannitol, 20 g / L soybean cake powder, 20 g / L agar, and 5 g / L folate, and the pH value before disinfection is 7.
2.
7. The method according to any one of claims 3 to 6, characterized in that: The temperature of the aerobic growth is 26-30° C., preferably 28° C.; the time of the aerobic growth is 7-10 days, preferably 8 days.
8. A method for preparing 5-ketomilbemycin, characterized in that: The Streptomyces HS-5-OXO-MIL-116 described in claim 1 is used for aerobic fermentation in a nutrient medium containing assimilable carbon source and / or nitrogen source and nitrate.
9. The method according to claim 8, characterized in that: The assimilable carbon source in the nutrient medium is selected from one of soluble starch, maltodextrin, sucrose, glucose, glycerol, fructose, sorbitol, mannitol, maltose, lactose, galactose, xylan, industrial molasses, or a combination of the above substances, preferably sucrose.
10. The method according to claim 8, characterized in that The assimilable nitrogen source in the nutrient medium is selected from soybean cake powder, yeast extract, malt extract, skimmed milk powder, yeast extract powder, yeast peptone, peanut cake powder, yeast powder, corn steep powder, gluten powder, wheat germ flakes, soy peptone, corn flour, soybean meal, or a combination of the above substances, preferably a combination of soybean cake powder, peanut cake powder, gluten powder, or corn flour with yeast extract or malt extract, and further preferably a combination of soybean cake powder, yeast extract and malt extract.
11. The method according to any one of claims 8 to 10, characterized in that: The nutrient medium also includes an inorganic salt, which is selected from one of zinc sulfate, magnesium sulfate, ferrous sulfate, copper sulfate, manganese sulfate, dipotassium hydrogen phosphate, potassium chloride, sodium chloride, magnesium chloride, cobalt chloride, sodium molybdate, trisodium citrate, calcium carbonate, calcium chloride, or a combination of the above substances, preferably a combination of ferrous sulfate, dipotassium hydrogen phosphate, calcium carbonate, and magnesium sulfate.
12. The method according to any one of claims 8 to 11, characterized in that: The nutrient medium contains sucrose, soybean cake powder, malt extract, yeast extract, dipotassium hydrogen phosphate, magnesium sulfate, ferrous sulfate, calcium carbonate, and folate; preferably, the nutrient medium contains 100-500 g / L sucrose, 10-50 g / L soybean cake powder, 1-10 g / L malt extract, 1-10 g / L yeast extract, 0.01-0.1 g / L ferrous sulfate, 0.1-1 g / L dipotassium hydrogen phosphate, 0.1-1 g / L magnesium sulfate, 1-10 g / L calcium carbonate, and 1-10 g / L folate; further preferably, the nutrient medium contains 160 g / L sucrose, 20 g / L soybean cake powder, 5 g / L malt extract, 5 g / L yeast extract, 0.05 g / L ferrous sulfate, 0.5 g / L dipotassium hydrogen phosphate, 0.5 g / L magnesium sulfate, 3.0 g / L calcium carbonate, and 2 g / L folate.
13. The method according to any one of claims 8 to 12, characterized in that: The temperature of the aerobic fermentation is 26-30° C., preferably 28° C.; the pH of the nutrient medium is 6.0-8.0, preferably 6.8-7.2; and the time of the aerobic fermentation is 240-400 hours, preferably 264-312 hours.
Citation Information
Cited By
5-ketomilbemycin-producing bacterium and use thereof
WO2026001872A1
